-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Keji Pharmaceutical-B (02171.HK) announced that the preliminary results of CT0596 (an allogeneic CAR-T cell candidate product targeting BCMA) were reported at the 67th American Society of Hematology (ASH) Annual Meeting.

Zhitongcaijing·12/08/2025 00:17:04
Listen to the news
Zhitong Finance App News, Keji Pharmaceutical-B (02171.HK) announced that the preliminary results of CT0596 (an allogeneic CAR-T cell candidate product targeting BCMA) were reported at the 67th American Society of Hematology (ASH) Annual Meeting.